Company　History

• August 1979Incorporated as a private limited company in Koganei-shi, Tokyo
• May 1983Constructed Tochigi Plant
• July 1985Aquired manufacturing approval of MYCELL® HBsAg, the first diagnostic reagent product of our company
• May 1986Head office moved to Koraku, Bunkyo-ku, Tokyo（Current address）
• March 2002Contributed to the establishment of EpiPhoenix Co., Ltd.（presently PhoenixBio Co., Ltd.), a University of Hiroshima-based venture specializing in chimeric mice
• October 2013Absorbed BioMedics Japan Inc.
• April 2014Acquired Utsunomiya Office from Phoenix Bio Co., Ltd. Due to corporate division.
• April 2015Acquired of patent licensing right of CRISPR/Cas9 system from Broad Institute. Acquired of patent licensing right to establish iPS cell and gene recombination from iPS Academia Japan.
• August 2015Acquired ISO13485.
• July 2022The completion of the second Plant building at the Tochigi Plant.